APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rebamipide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rebamipide Industry Growth and Trends Forecast to 2032

Report ID 17403114012 January 2026107 pages

Choose your research edition.

Industry ResearchRebamipide Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Rebamipide Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Rebamipide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rebamipide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rebamipide Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Rebamipide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rebamipide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rebamipide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rebamipide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rebamipide include Yuanlijian Pharmaceutical, Dong Wha Pharm, Suzhou Tianma Pharmaceutical Group, Cheer Fine Pharmaceutical, Menovo, Pfizer, Otsuka Pharmaceutical, Strides Pharma Science and Saurav Chemicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rebamipide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rebamipide market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rebamipide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rebamipide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rebamipide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rebamipide Market by Company

Yuanlijian Pharmaceutical

Dong Wha Pharm

Suzhou Tianma Pharmaceutical Group

Cheer Fine Pharmaceutical

Menovo

Pfizer

Otsuka Pharmaceutical

Strides Pharma Science

Saurav Chemicals

SAMOH Pharm

Macleods Pharma

Kyung Dong Pharm

Anlon Healthcare Pvt Ltd

Rebamipide Segment by Type

Pharmacy

Capsule

Rebamipide Segment by Application

Pharmacy

Hospital

Others

Rebamipide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rebamipide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rebamipide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rebamipide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rebamipide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rebamipide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pharmacy Table 2. Major Company of Capsule Table 3. Global Rebamipide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Rebamipide Sales by Type (2021-2026) & (K Units) Table 5. Global Rebamipide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Rebamipide Sales Market Share in Value by Type (2021-2026) Table 8. Global Rebamipide Price by Type (2021-2026) & (US$/Unit) Table 9. Global Rebamipide Sales by Type (2027-2032) & (K Units) Table 10. Global Rebamipide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Rebamipide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Rebamipide Sales Market Share in Value by Type (2027-2032) Table 13. Global Rebamipide Price by Type (2027-2032) & (US$/Unit) Table 14. North America Rebamipide Sales by Type (2021-2026) & (K Units) Table 15. North America Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Rebamipide Sales by Type (2021-2026) & (K Units) Table 17. Europe Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Rebamipide Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Rebamipide Sales by Type (2021-2026) & (K Units) Table 21. Latin America Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Rebamipide Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Rebamipide Sales by Type (2021-2026) & (US$ Million) Table 24. Rebamipide Industry Trends Table 25. Rebamipide Industry Drivers Table 26. Rebamipide Industry Opportunities and Challenges Table 27. Rebamipide Industry Restraints Table 28. Global Rebamipide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Rebamipide Revenue Market Share by Company (2021-2026) Table 30. Global Rebamipide Sales by Company (2021-2026) & (K Units) Table 31. Global Rebamipide Sales Share by Company (2021-2026) Table 32. Global Rebamipide Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Rebamipide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Rebamipide Major Company Production Sites and Headquarters Table 35. Global Rebamipide Company, Product Type & Application Table 36. Global Rebamipide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Rebamipide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Rebamipide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Rebamipide Sales by Region (2021-2026) & (K Units) Table 41. Global Rebamipide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Rebamipide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Rebamipide Sales Market Share in Value by Region (2021-2026) Table 44. Global Rebamipide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Rebamipide Sales by Region (2027-2032) & (K Units) Table 46. Global Rebamipide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Rebamipide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Rebamipide Sales Market Share in Value by Region (2027-2032) Table 49. Global Rebamipide Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Rebamipide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Rebamipide Sales by Application (2021-2026) & (K Units) Table 52. Global Rebamipide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Rebamipide Sales Market Share in Value by Application (2021-2026) Table 55. Global Rebamipide Price by Application (2021-2026) & (US$/Unit) Table 56. Global Rebamipide Sales by Application (2027-2032) & (K Units) Table 57. Global Rebamipide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Rebamipide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Rebamipide Sales Market Share in Value by Application (2027-2032) Table 60. Global Rebamipide Price by Application (2027-2032) & (US$/Unit) Table 61. North America Rebamipide Sales by Application (2021-2026) & (K Units) Table 62. North America Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Rebamipide Sales by Application (2021-2026) & (K Units) Table 64. Europe Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Rebamipide Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Rebamipide Sales by Application (2021-2026) & (K Units) Table 68. Latin America Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Rebamipide Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Rebamipide Sales by Application (2021-2026) & (US$ Million) Table 71. Yuanlijian Pharmaceutical Company Information Table 72. Yuanlijian Pharmaceutical Business Overview Table 73. Yuanlijian Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yuanlijian Pharmaceutical Rebamipide Product Portfolio Table 75. Yuanlijian Pharmaceutical Recent Development Table 76. Dong Wha Pharm Company Information Table 77. Dong Wha Pharm Business Overview Table 78. Dong Wha Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dong Wha Pharm Rebamipide Product Portfolio Table 80. Dong Wha Pharm Recent Development Table 81. Suzhou Tianma Pharmaceutical Group Company Information Table 82. Suzhou Tianma Pharmaceutical Group Business Overview Table 83. Suzhou Tianma Pharmaceutical Group Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Suzhou Tianma Pharmaceutical Group Rebamipide Product Portfolio Table 85. Suzhou Tianma Pharmaceutical Group Recent Development Table 86. Cheer Fine Pharmaceutical Company Information Table 87. Cheer Fine Pharmaceutical Business Overview Table 88. Cheer Fine Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Cheer Fine Pharmaceutical Rebamipide Product Portfolio Table 90. Cheer Fine Pharmaceutical Recent Development Table 91. Menovo Company Information Table 92. Menovo Business Overview Table 93. Menovo Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Menovo Rebamipide Product Portfolio Table 95. Menovo Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Pfizer Rebamipide Product Portfolio Table 100. Pfizer Recent Development Table 101. Otsuka Pharmaceutical Company Information Table 102. Otsuka Pharmaceutical Business Overview Table 103. Otsuka Pharmaceutical Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Otsuka Pharmaceutical Rebamipide Product Portfolio Table 105. Otsuka Pharmaceutical Recent Development Table 106. Strides Pharma Science Company Information Table 107. Strides Pharma Science Business Overview Table 108. Strides Pharma Science Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Strides Pharma Science Rebamipide Product Portfolio Table 110. Strides Pharma Science Recent Development Table 111. Saurav Chemicals Company Information Table 112. Saurav Chemicals Business Overview Table 113. Saurav Chemicals Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Saurav Chemicals Rebamipide Product Portfolio Table 115. Saurav Chemicals Recent Development Table 116. SAMOH Pharm Company Information Table 117. SAMOH Pharm Business Overview Table 118. SAMOH Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. SAMOH Pharm Rebamipide Product Portfolio Table 120. SAMOH Pharm Recent Development Table 121. Macleods Pharma Company Information Table 122. Macleods Pharma Business Overview Table 123. Macleods Pharma Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Macleods Pharma Rebamipide Product Portfolio Table 125. Macleods Pharma Recent Development Table 126. Kyung Dong Pharm Company Information Table 127. Kyung Dong Pharm Business Overview Table 128. Kyung Dong Pharm Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Kyung Dong Pharm Rebamipide Product Portfolio Table 130. Kyung Dong Pharm Recent Development Table 131. Anlon Healthcare Pvt Ltd Company Information Table 132. Anlon Healthcare Pvt Ltd Business Overview Table 133. Anlon Healthcare Pvt Ltd Rebamipide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Anlon Healthcare Pvt Ltd Rebamipide Product Portfolio Table 135. Anlon Healthcare Pvt Ltd Recent Development Table 136. North America Rebamipide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Rebamipide Sales by Country (2021-2026) & (K Units) Table 138. North America Rebamipide Sales Market Share by Country (2021-2026) Table 139. North America Rebamipide Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Rebamipide Sales Market Share Forecast by Country (2027-2032) Table 141. North America Rebamipide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Rebamipide Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Rebamipide Market Share by Country (2021-2026) Table 144. North America Rebamipide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Rebamipide Market Share Forecast by Country (2027-2032) Table 146. Europe Rebamipide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Rebamipide Sales by Country (2021-2026) & (K Units) Table 148. Europe Rebamipide Sales Market Share by Country (2021-2026) Table 149. Europe Rebamipide Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Rebamipide Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Rebamipide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Rebamipide Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Rebamipide Market Share by Country (2021-2026) Table 154. Europe Rebamipide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Rebamipide Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Rebamipide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Rebamipide Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Rebamipide Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Rebamipide Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Rebamipide Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Rebamipide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Rebamipide Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Rebamipide Market Share by Country (2021-2026) Table 164. Asia-Pacific Rebamipide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Rebamipide Market Share Forecast by Country (2027-2032) Table 166. Latin America Rebamipide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Rebamipide Sales by Country (2021-2026) & (K Units) Table 168. Latin America Rebamipide Sales Market Share by Country (2021-2026) Table 169. Latin America Rebamipide Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Rebamipide Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Rebamipide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Rebamipide Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Rebamipide Market Share by Country (2021-2026) Table 174. Latin America Rebamipide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Rebamipide Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Rebamipide Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Rebamipide Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Rebamipide Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Rebamipide Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Rebamipide Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Rebamipide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Rebamipide Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Rebamipide Market Share by Country (2021-2026) Table 184. Middle East and Africa Rebamipide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Rebamipide Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Rebamipide Distributors List Table 189. Rebamipide Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Rebamipide Image Figure 2. Global Rebamipide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rebamipide Market Size (2021-2032) & (US$ Million) Figure 4. Global Rebamipide Sales (2021-2032) & (K Units) Figure 5. Pharmacy Image Figure 6. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Rebamipide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Rebamipide Market Share by Type 2025 VS 2032 Figure 11. North America Rebamipide Sales Market Share in Volume by Type in 2025 Figure 12. North America Rebamipide Sales Market Share in Value by Type in 2025 Figure 13. Europe Rebamipide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Rebamipide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Rebamipide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Rebamipide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Rebamipide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Rebamipide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Rebamipide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Rebamipide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Rebamipide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmacy Image Figure 24. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Rebamipide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Rebamipide Market Share by Application 2025 VS 2032 Figure 31. North America Rebamipide Sales Market Share in Volume by Application in 2025 Figure 32. North America Rebamipide Sales Market Share in Value by Application in 2025 Figure 33. Europe Rebamipide Sales Market Share in Volume by Application in 2025 Figure 34. Europe Rebamipide Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Rebamipide Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Rebamipide Sales Market Share in Value by Application in 2025 Figure 37. Latin America Rebamipide Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Rebamipide Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Rebamipide Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Rebamipide Sales Market Share in Value by Application in 2025 Figure 41. North America Rebamipide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Rebamipide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Rebamipide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Rebamipide Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Rebamipide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Rebamipide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rebamipide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rebamipide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Rebamipide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Rebamipide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rebamipide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Rebamipide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Rebamipide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Rebamipide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rebamipide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Rebamipide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Rebamipide Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Rebamipide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rebamipide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Rebamipide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Rebamipide Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Rebamipide Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmacy
  • Capsule
Applications
  • Pharmacy
  • Hospital
  • Others
Companies covered
  • Yuanlijian Pharmaceutical
  • Dong Wha Pharm
  • Suzhou Tianma Pharmaceutical Group
  • Cheer Fine Pharmaceutical
  • Menovo
  • Pfizer
  • Otsuka Pharmaceutical
  • Strides Pharma Science
  • Saurav Chemicals
  • SAMOH Pharm
  • Macleods Pharma
  • Kyung Dong Pharm
  • Anlon Healthcare Pvt Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rebamipide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rebamipide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rebamipide Market by Type
  6. 1.3.1 Pharmacy
  7. 1.3.2 Capsule
  8. 1.4 Global Rebamipide Market Size by Type
  9. 1.4.1 Global Rebamipide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Rebamipide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Rebamipide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Rebamipide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Rebamipide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Rebamipide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Rebamipide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Rebamipide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rebamipide Industry Trends
  2. 2.2 Rebamipide Industry Drivers
  3. 2.3 Rebamipide Industry Opportunities and Challenges
  4. 2.4 Rebamipide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rebamipide Revenue (2021-2026)
  2. 3.2 Global Top Players by Rebamipide Sales (2021-2026)
  3. 3.3 Global Top Players by Rebamipide Price (2021-2026)
  4. 3.4 Global Rebamipide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rebamipide Major Company Production Sites & Headquarters
  6. 3.6 Global Rebamipide Company, Product Type & Application
  7. 3.7 Global Rebamipide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rebamipide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rebamipide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rebamipide Tier 1, Tier 2, and Tier 3
4 Rebamipide Regional Status and Outlook
  1. 4.1 Global Rebamipide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rebamipide Historic Market Size by Region
  3. 4.2.1 Global Rebamipide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rebamipide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rebamipide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rebamipide Forecasted Market Size by Region
  7. 4.3.1 Global Rebamipide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rebamipide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rebamipide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rebamipide by Application
  1. 5.1 Rebamipide Market by Application
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Rebamipide Market Size by Application
  6. 5.2.1 Global Rebamipide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rebamipide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rebamipide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rebamipide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rebamipide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rebamipide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rebamipide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rebamipide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yuanlijian Pharmaceutical
  2. 6.1.1 Yuanlijian Pharmaceutical Company Information
  3. 6.1.2 Yuanlijian Pharmaceutical Business Overview
  4. 6.1.3 Yuanlijian Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yuanlijian Pharmaceutical Rebamipide Product Portfolio
  6. 6.1.5 Yuanlijian Pharmaceutical Recent Developments
  7. 6.2 Dong Wha Pharm
  8. 6.2.1 Dong Wha Pharm Company Information
  9. 6.2.2 Dong Wha Pharm Business Overview
  10. 6.2.3 Dong Wha Pharm Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dong Wha Pharm Rebamipide Product Portfolio
  12. 6.2.5 Dong Wha Pharm Recent Developments
  13. 6.3 Suzhou Tianma Pharmaceutical Group
  14. 6.3.1 Suzhou Tianma Pharmaceutical Group Company Information
  15. 6.3.2 Suzhou Tianma Pharmaceutical Group Business Overview
  16. 6.3.3 Suzhou Tianma Pharmaceutical Group Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Suzhou Tianma Pharmaceutical Group Rebamipide Product Portfolio
  18. 6.3.5 Suzhou Tianma Pharmaceutical Group Recent Developments
  19. 6.4 Cheer Fine Pharmaceutical
  20. 6.4.1 Cheer Fine Pharmaceutical Company Information
  21. 6.4.2 Cheer Fine Pharmaceutical Business Overview
  22. 6.4.3 Cheer Fine Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cheer Fine Pharmaceutical Rebamipide Product Portfolio
  24. 6.4.5 Cheer Fine Pharmaceutical Recent Developments
  25. 6.5 Menovo
  26. 6.5.1 Menovo Company Information
  27. 6.5.2 Menovo Business Overview
  28. 6.5.3 Menovo Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Menovo Rebamipide Product Portfolio
  30. 6.5.5 Menovo Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Rebamipide Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Otsuka Pharmaceutical
  38. 6.7.1 Otsuka Pharmaceutical Company Information
  39. 6.7.2 Otsuka Pharmaceutical Business Overview
  40. 6.7.3 Otsuka Pharmaceutical Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Otsuka Pharmaceutical Rebamipide Product Portfolio
  42. 6.7.5 Otsuka Pharmaceutical Recent Developments
  43. 6.8 Strides Pharma Science
  44. 6.8.1 Strides Pharma Science Company Information
  45. 6.8.2 Strides Pharma Science Business Overview
  46. 6.8.3 Strides Pharma Science Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Strides Pharma Science Rebamipide Product Portfolio
  48. 6.8.5 Strides Pharma Science Recent Developments
  49. 6.9 Saurav Chemicals
  50. 6.9.1 Saurav Chemicals Company Information
  51. 6.9.2 Saurav Chemicals Business Overview
  52. 6.9.3 Saurav Chemicals Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Saurav Chemicals Rebamipide Product Portfolio
  54. 6.9.5 Saurav Chemicals Recent Developments
  55. 6.10 SAMOH Pharm
  56. 6.10.1 SAMOH Pharm Company Information
  57. 6.10.2 SAMOH Pharm Business Overview
  58. 6.10.3 SAMOH Pharm Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SAMOH Pharm Rebamipide Product Portfolio
  60. 6.10.5 SAMOH Pharm Recent Developments
  61. 6.11 Macleods Pharma
  62. 6.11.1 Macleods Pharma Company Information
  63. 6.11.2 Macleods Pharma Business Overview
  64. 6.11.3 Macleods Pharma Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Macleods Pharma Rebamipide Product Portfolio
  66. 6.11.5 Macleods Pharma Recent Developments
  67. 6.12 Kyung Dong Pharm
  68. 6.12.1 Kyung Dong Pharm Company Information
  69. 6.12.2 Kyung Dong Pharm Business Overview
  70. 6.12.3 Kyung Dong Pharm Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kyung Dong Pharm Rebamipide Product Portfolio
  72. 6.12.5 Kyung Dong Pharm Recent Developments
  73. 6.13 Anlon Healthcare Pvt Ltd
  74. 6.13.1 Anlon Healthcare Pvt Ltd Company Information
  75. 6.13.2 Anlon Healthcare Pvt Ltd Business Overview
  76. 6.13.3 Anlon Healthcare Pvt Ltd Rebamipide Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Anlon Healthcare Pvt Ltd Rebamipide Product Portfolio
  78. 6.13.5 Anlon Healthcare Pvt Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Rebamipide Sales by Country
  2. 7.1.1 North America Rebamipide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rebamipide Sales by Country (2021-2026)
  4. 7.1.3 North America Rebamipide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rebamipide Market Size by Country
  6. 7.2.1 North America Rebamipide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rebamipide Market Size by Country (2021-2026)
  8. 7.2.3 North America Rebamipide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rebamipide Sales by Country
  2. 8.1.1 Europe Rebamipide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rebamipide Sales by Country (2021-2026)
  4. 8.1.3 Europe Rebamipide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rebamipide Market Size by Country
  6. 8.2.1 Europe Rebamipide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rebamipide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rebamipide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rebamipide Sales by Country
  2. 9.1.1 Asia-Pacific Rebamipide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rebamipide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rebamipide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rebamipide Market Size by Country
  6. 9.2.1 Asia-Pacific Rebamipide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rebamipide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rebamipide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rebamipide Sales by Country
  2. 10.1.1 South America Rebamipide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rebamipide Sales by Country (2021-2026)
  4. 10.1.3 South America Rebamipide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rebamipide Market Size by Country
  6. 10.2.1 South America Rebamipide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rebamipide Market Size by Country (2021-2026)
  8. 10.2.3 South America Rebamipide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rebamipide Sales by Country
  2. 11.1.1 Middle East and Africa Rebamipide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rebamipide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rebamipide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rebamipide Market Size by Country
  6. 11.2.1 Middle East and Africa Rebamipide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rebamipide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rebamipide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rebamipide Value Chain Analysis
  2. 12.1.1 Rebamipide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rebamipide Production Mode & Process
  7. 12.2 Rebamipide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rebamipide Distributors
  10. 12.2.3 Rebamipide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst